Original Research

Published on 13 May 2022

DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Mingyue Liu
Chang Xu
Xiaochun Qin
Wenwu Liu
Deping Li
Hui Jia
Xudong Gao
Yuting Wu
Qiong Wu
Xiangbo Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.873649

3,859 views
12 citations

Original Research

Published on 13 May 2022

Reclassification of Hepatocellular Cancer With Neural-Related Genes

in Pharmacology of Anti-Cancer Drugs

Yi-Gan Zhang
Ming-Zhu Jin
Xiao-Ran Zhu
Wei-Lin Jin

Frontiers in Oncology

doi 10.3389/fonc.2022.877657

3,664 views
6 citations

Original Research

Published on 12 May 2022

Arsenic Trioxide Therapy During Pregnancy: ATO and Its Metabolites in Maternal Blood and Amniotic Fluid of Acute Promyelocytic Leukemia Patients

in Pharmacology of Anti-Cancer Drugs

Meihua Guo
Jian Lv
Xiaotong Chen
Mengliang Wu
Qilei Zhao
Xin Hai

Frontiers in Oncology

doi 10.3389/fonc.2022.887026

2,160 views
3 citations

Original Research

Published on 12 May 2022

Comprehensive Analysis of Sterol O-Acyltransferase 1 as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma

in Pharmacology of Anti-Cancer Drugs

Xuyang Guo
Shaolong Zhou
Zhuo Yang
Zi-An Li
Weihua Hu
Lirui Dai
Wulong Liang
Xinjun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.896433

3,433 views
9 citations

Original Research

Published on 12 May 2022

Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer

in Pharmacology of Anti-Cancer Drugs

Weijia Zhang
Shuyi Sang
Chang Peng
George Q. Li
Ling Ou
Zhong Feng
Yuanjing Zou
Yuemei Yuan
Meicun Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.807718

3,522 views
5 citations

Original Research

Published on 11 May 2022

Characterization of Anti-Cancer Activities of Violacein: Actions on Tumor Cells and the Tumor Microenvironment

in Pharmacology of Anti-Cancer Drugs

Charlotte Dahlem
Shilpee Chanda
Jan Hemmer
Hanna S. Schymik
Michael Kohlstedt
Christoph Wittmann
Alexandra K. Kiemer

Frontiers in Oncology

doi 10.3389/fonc.2022.872223

3,237 views
6 citations

Original Research

Published on 11 May 2022

Study on the Mechanism of Sancao Tiaowei Decoction in the Treatment of MNNG-Induced Precancerous Lesions of Gastric Carcinoma Through Hedgehog Signaling Pathway

in Pharmacology of Anti-Cancer Drugs

Yeon Chae

Frontiers in Oncology

doi 10.3389/fonc.2022.841553

3,259 views
5 citations

Original Research

Published on 11 May 2022

Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress

in Pharmacology of Anti-Cancer Drugs

Qi Li
Qi Tan
Yangfei Ma
Zehui Gu
Suxian Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.903394

2,585 views
9 citations

Original Research

Published on 10 May 2022

3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages

in Pharmacology of Anti-Cancer Drugs

Gangqi Sun
Xiaojuan Hou
Luyao Zhang
Hengyan Zhang
Changchun Shao
Fengwei Li
Chen Zong
Rong Li
Junxia Shi
Xue Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.877982

2,529 views
4 citations

Original Research

Published on 10 May 2022

Synergistic Radiosensitization Mediated by Chemodynamic Therapy via a Novel Biodegradable Peroxidases Mimicking Nanohybrid

in Pharmacology of Anti-Cancer Drugs

Jun Zhang
Dazhen Jiang
Meng Lyu
Shiqi Ren
Yunfeng Zhou
Zhen Cao

Frontiers in Oncology

doi 10.3389/fonc.2022.872502

1,625 views
3 citations

Systematic Review

Published on 10 May 2022

Comparative Efficacy and Safety of Anti-PD-1/PD-L1 for the Treatment of Non-Small Cell Lung Cancer: A Network Meta-Analysis of 13 Randomized Controlled Studies

in Pharmacology of Anti-Cancer Drugs

Maofen Jiang
Chunjiao Liu
Dongxiao Ding
Hui Tian
Chaoqun Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.827050

5,643 views
3 citations

Original Research

Published on 10 May 2022

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma

in Pharmacology of Anti-Cancer Drugs

Matthias A. Fante
Mona Felsenstein
Stephanie Mayer
Michael Gerken
Monika Klinkhammer-Schalke
Wolfgang Herr
Martin Vogelhuber
Albrecht Reichle
Daniel Heudobler

Frontiers in Oncology

doi 10.3389/fonc.2022.852987

2,554 views
3 citations

Original Research

Published on 09 May 2022

Transfer of IGF2BP3 Through Ara-C-Induced Apoptotic Bodies Promotes Survival of Recipient Cells

in Pharmacology of Anti-Cancer Drugs

Junjie Gou
Hongjiao Li
Jingjing Bi
Xingchen Pang
Xiang Li
Yi Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.801226

2,703 views
5 citations

Original Research

Published on 09 May 2022

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis

in Pharmacology of Anti-Cancer Drugs

Tong Xu
Yanyu Jiang
Shuying Yuan
Li Zhang
Xihui Chen
Weili Zhao
Lili Cai
Biying Xiao
Lijun Jia

Frontiers in Oncology

doi 10.3389/fonc.2022.899402

3,932 views
6 citations

Review

Published on 06 May 2022

Research Advances on Anti-Cancer Natural Products

in Pharmacology of Anti-Cancer Drugs

Meng Guo
Jie Jin
Dong Zhao
Zheng Rong
Lu-Qi Cao
Ai-Hong Li
Xiao-Ying Sun
Li-Yi Jia
Yin-Di Wang
Ling Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.866154

6,066 views
32 citations

Original Research

Published on 05 May 2022

QKI-6 Suppresses Cell Proliferation, Migration, and EMT in Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Haihua Zhang
Junqiang Li
Feng Tian
Xuan Su
Xinxin Wang
Di Tang
Lei Zhang
Tao Zhang
Yunfeng Ni

Frontiers in Oncology

doi 10.3389/fonc.2022.897553

2,673 views
7 citations

Navigation group

Articles

DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer

Reclassification of Hepatocellular Cancer With Neural-Related Genes

Arsenic Trioxide Therapy During Pregnancy: ATO and Its Metabolites in Maternal Blood and Amniotic Fluid of Acute Promyelocytic Leukemia Patients

Comprehensive Analysis of Sterol O-Acyltransferase 1 as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma

Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer

Characterization of Anti-Cancer Activities of Violacein: Actions on Tumor Cells and the Tumor Microenvironment

Study on the Mechanism of Sancao Tiaowei Decoction in the Treatment of MNNG-Induced Precancerous Lesions of Gastric Carcinoma Through Hedgehog Signaling Pathway

Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress

3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages

Synergistic Radiosensitization Mediated by Chemodynamic Therapy via a Novel Biodegradable Peroxidases Mimicking Nanohybrid

Comparative Efficacy and Safety of Anti-PD-1/PD-L1 for the Treatment of Non-Small Cell Lung Cancer: A Network Meta-Analysis of 13 Randomized Controlled Studies

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma

Transfer of IGF2BP3 Through Ara-C-Induced Apoptotic Bodies Promotes Survival of Recipient Cells

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis

Research Advances on Anti-Cancer Natural Products

QKI-6 Suppresses Cell Proliferation, Migration, and EMT in Non-Small Cell Lung Cancer